Astellas and YASKAWA Agree to Establish a Joint Venture Focused on Cell Therapy Manufacturing
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and YASKAWA Electric Corporation (TSE: 6506, President and CEO; Masahiro Ogawa, "YASKAWA") signed a definitive agreement to establish a joint venture for the development of a cell therapy product manufacturing platform utilizing the dual-arm robot "Maholo." In addition, the joint venture will offer platform access to startups and academic institutions, fostering collaboration and innovation in the field of cell therap